Position in IMVT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,128,335
+$1,706,609 QoQ
Shares Held
107,146
+9.9% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 226 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. IMVT ranks #64 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in IMVT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,128,335 | 107,146 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,421,726 | 97,493 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,207,650 | 86,847 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,595,444 | 98,973 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,622,096 | 101,381 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,427,954 | 83,555 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,004,685 | 80,932 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,273,501 | 79,744 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,205,244 | 83,532 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,461,020 | 76,169 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,132,744 | 74,359 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,862,550 | 74,565 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,369,596 | 72,198 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,111,260 | 71,648 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,239,695 | 69,842 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $348,091 | 62,382 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $226,882 | 58,175 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $250,506 | 45,464 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $387,566 | 45,489 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $400,522 | 46,090 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $467,299 | 44,210 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $673,006 | 41,958 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,019,103 | 43,713 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,328,422 | 37,750 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $557,639 | 22,901 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||